Authors : O. Eddarif; S. El Baz; A. Hamdan; K. Nouni; A. Lachgar; H. El Kacemi; T. Kebdani; K. Hassouni

Volume/Issue : Volume 9 - 2024, Issue 6 - June

Google Scholar : https://tinyurl.com/4ju95tws

Scribd : https://tinyurl.com/yyzfmcb3

DOI : https://doi.org/10.38124/ijisrt/IJISRT24JUN162

Abstract : The prognosis of breast cancer has significantly improved in recent years thanks to advances in therapeutic options. Quality of life is increasingly recognized as a fundamental criterion in evaluating treatment outcomes. This highlights the particular impact on sexuality. Our objective is to evaluate the sexual well-being of Moroccan individuals undergoing treatment for non-metastatic breast cancer. This is a retrospective study involving a series of 230 sexually active patients treated for breast cancer at the Radiotherapy Department of the National Institute of Oncology in Rabat between January 1, 2022, and July 31, 2022. Sexual function was assessed during the end-of- treatment consultation using the Relationship and Sexuality Scale (RSS).The mean age of the patients was 47.24 years with a range from 32 to 65 years .Surgical treatment was radical mastectomy in 44% of instances, conservative lumpectomy was performed along with axillary lymph node dissection in 56% of cases.. The majority of patients (85.2%) received chemotherapy. More than half of the participants (71%) received adjuvant hormone therapy. Hormone therapy consisted of tamoxifen in 67.3% of cases and aromatase inhibitors in 32.7%. In terms of sexual dysfunction, more than half of the patients (61%) reported impaired sexual functioning. Specifically, the frequency of sexual intercourse and sexual desire (RSS 3 and RSS 4) decreased in 54% and 43% of our patients, respectively. In 65% of patients (measured by RSS 8 and RSS 13), dissatisfaction was noted concerning the emotional relationship dynamics within the couple. Regarding apprehension regarding sexual intercourse, 23% of patients reported experiencing such fear. Therapeutic management appears to have an impact on sexual function in patients with breast cancer. It is important to consider these disorders during management given their frequency and their impact on quality of life, even remotely from treatment and in the absence of any signs of disease progression.

Keywords : Breast Cancer, Sexuallity, Treatment.

References :

1. Male DA, Fergus KD, Cullen K. Sexual identity after breast cancer:sexuality, body image, and relationship repercussions. Curr OpinSupport Palliat Care 2016;10(1):66—74.
2. Lee M, Kim YH, Jeon MJ. Risk factors for negative impacts on sexualactivity and function in younger breast cancer survivors. PsychoOncol 2015;24(9):1097—103.
3. Schover LR, Baum GP, Fuson LA, Brewster A, Melhem-BertrandtA. Sexual problems during the first 2 years of adjuvanttreatment with aromatase inhibitors. J Sex Med 2014;11(12):3102—11.
4. Raggio GA, Butryn ML, Arigo D, Mikorski R, Palmer SC. Prevalenceand correlates of sexual morbidity in long-term breast cancersurvivors. Psychol Health 2014;29(6):632—50.
5. Leila M, Nada C, Kais C, Jaweher M. Sexuality after breast can-cer: cultural specificities of Tunisian population. Pan Afr Med J2016;25.(1).
6. Maiorino MI, Chiodini P, Bellastella G, Giugliano D, Esposito K. Sexualdysfunction in women with cancer: a systematic review withmeta-analysis of studies using the female sexual function index.Endocrine 2016;54(2):329.
7. Berglund G, Nystedt M, Bolund C, Sjödén PO, Rutquist LE. Effectof endocrine treatment on sexuality in premenopausal breastcancer patients: a prospective randomized study. J Clin Oncol2001;19(11):2788—96.
8. Zaied S, Ben Fatma L, Laadhari A, Boudegga MZ, Hochlef M,Chabchoub I, et al. Étude de la sexualité chez les femmestunisiennes en rémission complète d’un cancer du sein nonmétastatique : à propos de 100 femmes. Bull Cancer 2013;7:689—96.
9. Emilee G, Ussher JM, Perz J. Sexuality after breast cancer: a review.Maturitas 2010;66(4):397—407.
10. Castelo ARP, Oriá MOB, Chaves AFL, Bezerra KC, Fernandes AFC,Vasconcelos CTM, et al. The impact of breast cancer on femalesexuality: an integrative literature review. Glob J Health Sci2017;9(5):180.
11. Ouahbi H, El’emrabet FZ, Amaadour L, Benhami M, Sy O, Benbra-him Z, et al. Sexuality and quality of life of the young womanwith breast cancer in a Moroccan context: experience of themedical oncology department CHU Hassan II FEZ. The Breast2017;32:S86.
12. Alacacioglu A, Ulger E, Varol U, Yildiz I, Salman T, Bayoglu V, et al.Depression, anxiety and sexual satisfaction in breast cancerpatients and their partners-izmir oncology group study. AsianPac J Cancer Prev 2014;15(24):10631—6.
13. Shandiz FH, Karimi FZ, Rahimi N, Abdolahi M, Anbaran ZK, Gha-semi M, et al. Investigating sexual function and affecting factorsin women with breast cancer in Iran. Asian Pac J Cancer Prev2016;17(7):3583—6.
14. Boquiren VM, Esplen MJ, Wong J, Toner B, Warner E, Malik N. Sexualfunctioning in breast cancer survivors experiencing body imagedisturbance. Psycho Oncol 2016;25(1):66—76.
15. This P, Lachowsky M. Après un cancer gynécologique, comment bien vivre sa sexualité?. Oncologie. 1 avr 2008;10(4): 250-3.
16. Ellouz F, Marrakchi N, Raies H, Masmoudi S, Mezlini A, M´rad MF. Dysfonction sexuelle chez 100 femmes tunisiennes atteintes d´un cancer du sein. Sexologies. 1 janv 2019;28(1): 43-8.
17. Brédart A, Dolbeault S, Savignoni A, Besancenet C, This P, Giami A et al. Prevalence and associated factors of sexual problems after early-stage breast cancer treatment: results of a French exploratory survey. Psychooncology août 2011;20(8): 841-50.
18. Jeannin N, Pelletti CL D. La profession infirmière face à l´annonce en cancérologie?: place et enjeux de la dimension psychologique. Prat Organ Soins. 24 oct 2012; 43(3): 177-85.
19. Kwait RM, Pesek S, Onstad M, Edmonson D, Clark MA, Raker C et al. Influential forces in breast cancer surgical decision making and the impact on body image and sexual function. Ann Surg Oncol. oct 2016;23(10): 3403-11.
20. Cortés-Flores AO, Vargas-Meza A, Morgan- Villela G, Jiménez-Tornero J, del Valle CJZF, Solano-Genesta M et al. Sexuality among women treated for breast cancer: a survey of three surgical procedures. Aesthetic Plast Surg.déc 2017;41(6): 1275-9.
21. Aerts L, Christiaens MR, Enzlin P, Neven P, Amant F. Sexual functioning in women after mastectomy versus breast conserving therapy for early-stage breast cancer: a prospective controlled study. Breast. 2014 Oct;23(5):629-36. doi: 10.1016/j.breast.2014.06.012. Epub 2014 Jul 28. PMID: 25082211.
22. Jankowska M. Sexual functioning in young women in the con-text of breast cancer treatment. Rep Pract Oncol Radiother2013;18(4):193—200.
23. Malinovszky KM, Gould A, Foster E, Cameron D, Humphreys A, Crown J et al. Quality of life and sexual function after high-dose or conventional chemotherapy for high-risk breast cancer. Br J Cancer. 18 déc 2006;95(12):1626-31.
24. Ganz PA, Desmond KA, Belin TR, Meyerowitz BE, Rowland JH. Predictors of sexual health in women after a breast cancer diagnosis. J ClinOncol. août 1999;17(8): 2371-80.
25. Qi A, Li Y, Sun H, Jiao H, Liu Y, Chen Y. Incidence and risk factors of sexual dysfunction in young breast cancer survivors. Ann Palliat Med. 2021 Apr;10(4):4428-4434. doi: 10.21037/apm-21-352. PMID: 33966393.
26. Fourati A, Louchez M-M, Fournier J, Gamoudi A, Rahal K, El May M-V et al. Screening for common mutations in BRCA1 and BRCA2 genes: interest in genetic testing of Tunisian families with breast and/or ovarian cancer. Bull Cancer (Paris). Nov 2014;101(11): E36-40.
27. Beck AM, Robinson JW, Carlson LE. Sexual intimacy in heterosexual couples after prostate cancer treatment: what we know and what we still need to learn. Urol Oncol. avr 2009;27(2):137-43.
28. Baumgart J, Nilsson K, Evers AS, Kallak TK, Poromaa IS. Sexual dysfunction in women on adjuvant endocrine therapy after breast cancer. Menopause. 2013 Feb;20(2):162-8. doi: 10.1097/gme.0b013e31826560da. PMID: 22990756.